- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
Q2 2019 Novo Nordisk A/S Earnings Call Transcript
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to today's Q2 2019, Novo Nordisk AS Earnings Conference Call. (Operator Instructions) This conference is being recorded today, Friday 9 of August 2019.
I would now like to hand the conference over to your speaker today, Lars Fruergaard Jørgensen, the CEO. Please go ahead, sir.
¸ - /-&
Thank you very much. Welcome to this Novo Nordisk conference call regarding our performance in the first 6 months of 2019 and our performance -- sorry, our outlook for the year.
I'm Lars Fruergaard Jørgensen, the CEO of Novo Nordisk. With me I have our Chief Financial Officer, Karsten Knudsen; and our Chief Science Officer, Mads Krogsgaard Thomsen.
Today's earnings release and the slides for this call are available on our website, novonordisk.com. The call is scheduled to last for 1 hour. The presentation is structured as outlined on Slide 2, please note
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |